Professional Documents
Culture Documents
Laboratory Management
Laboratory Management
Laboratory
Management
Geoffrey Baird, MD, PhD
Chair, Laboratory Medicine and Pathology
University of Washington, Seattle, WA USA
August, 2021
Speaker affiliation
o Affiliations: Department of Laboratory Medicine and Pathology,
University of Washington, Seattle, WA, USA
Beneficence
◦ Do “what is best,” which can be nothing
Non-maleficence
◦ Primum non nocere, i.e. “do no harm”
Justice
◦ Deal with limited resources, allocate resources, recognize decisions could burden others, treat others
equitably
EFLM Syllabus Course
Beauchamp T, Childress J. Principles of Biomedical Ethics, 7th Edition. New York: Oxford University Press, 2013.
Beneficence
◦ Disclosure in general is a requirement for “informed” consent
◦ Disclosure has often been shown to have a benefit (in terms of later litigation, etc…)
Non-maleficence
◦ Misleading patients might harm them emotionally, ie dishonesty is “bad”
◦ Telling patients bad news or about errors might harm them psychologically more than an
inconsequential error
Justice
◦ Where is justice without truth?
Key Points:
Problems in different domains tend to occur together (consider as a Bayesian….one problem
tends to increase the pretest probability of related problems)
If you do a performance improvement plan correctly, there are only two outcomes: they get
better, or they leave.
New Case Study -Urinalysis
You have run manual urinalysis for decades, and are considering
purchasing an automated platform. One of the senior Medical
Laboratory Scientists who has overseen the urinalysis bench for
decades, and has taught generations of others how to interpret urine
sediments, does not like any of the instruments that have been
evaluated. After purchase, validation and implementation of an
instrument, you discover that this MLS performs manual microscopy
on every sample regardless of the automated instrument’s findings,
periodically overruling the instrument. Other staff are confused as to
what to do about this.
Urinalysis follow up
§We are an aging profession, at least in the US. Automation can
be seen as a threat, as it is unfamiliar and can replace some (but
not all) human functions
§There is no standardized approach to speaking with this MLS
(Emotional Intelligence)
§Recognize that in the organizational chart, there are individuals
at the top levels who are tasked with harder, broader goals and
who have more discretion about what methods to employ to
meet those goals. Those further down the organizational chart
have less discretion in choosing how to meet their obligations.
Case Study – An underperforming lab
§ One of your clinical labs has high employee turnover, with
several medical laboratory scientists quitting in the last
month. One faculty member tells you they are looking
elsewhere for new employment. Clinical quality does not
seem affected, but the group works long hours and is falling
behind because there is too much work to get through each
day.
Underperforming lab – next steps
§ Collect data – broad, structured interviews, review
performance metrics
§ Develop plan – respect all feedback (although not all
will be followed)
§ Communicate plan, expectations, timeline
§ Execute and TRACK
Test your knowledge
If you have carefully followed this lecture, you will know the answers to these
questions:
True/False: Emotional Intelligence can be more important for leaders/managers in the
clinical laboratory than subject matter expertise.
What do you consider to be the important features of an error disclosure to a patient or
physician?
What are the elements of a strong performance improvement plan?